Brief: Synact Pharma Management, Chairman Have Acquired Shares
Dec 22 (Reuters) - SynAct Pharma AB SYNACT.ST: SYNACT PHARMA MANAGEMENT AND CHAIRMAN OF THE BOARD HAVE ACQUIRED SHARES SYNTACT EXECUTIVES AND CHAIRMAN BUY SHARES CHAIRMAN OF BOARD, ANDERS KRONBORG HAS ACQUIRED 3,470 SHARES CEO JEPPE ØVLESEN, CSO THOMAS JONASSEN, AND CBO MADS BJERREGAARD, HAVE ACQUIRED 8,558 SHARES Source text: ID:nMFN65sxYB Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026